6.1 Pharmaceuticals
Main inclusion criteria
Clinical application and evaluation of pharmaceutical small molecules, therapeutic vaccines, antibodies and hormones in humans including:
- small scale settings and pilot studies
- phase I, II, III and IV trials
- assessing sensitivity, efficacy, specificity, relapse, survival, therapeutic value, pharmacokinetics, reproducibility and safety
- studies monitoring response, outcome, drug resistance and side effects
Advice on research activities
Includes studies of nutritional supplements used as treatments for disease.
Excludes studies focused on the potentially chemopreventative / health protective effects of specific nutrients, probiotics and nutritional supplements, which should be coded 3.3 Nutritional Prevention.
Official terminology
|
Full name of code |
Short name | Unique ID |
| 6.1 Pharmaceuticals | 6.1 Pharmaceutical |
HRCS_RA_6_1 |
Related external links
Common Scientific Outline (CSO) – 5.4 Systemic Therapies – Clinical Applications